Related Experiment Video

Updated: Jun 6, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Targeting Mitotic Exit in Malignant Cells

Christine Greil1, Monika Engelhardt1, Julia Felthaus1

  • 1Faculty of Medicine, Department of Medicine I, Medical Center, University of Freiburg, Freiburg, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|November 29, 2024
PubMed

Insights

Cancer cells can evade antimitotic drugs through cell cycle regulation. Combining therapies targeting the anaphase-promoting complex (APC/C) and cyclin B degradation may improve cancer treatment by enhancing mitotic arrest and apoptosis.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Cell cycle regulation is crucial for genomic stability, preventing malignant transformation.
  • Aberrant cell cycle regulation and mitotic defects are hallmarks of cancer, targeted by therapies.
  • Cancer cells can exhibit resistance to antimitotic drugs via mitotic slippage, involving the anaphase-promoting complex (APC/C) and cyclin B degradation.

Purpose of the Study:

  • To investigate the impact of antimitotic agents and their combinations on mitosis and apoptosis.
  • To clarify the mechanisms of conventional spindle poisons and novel targeted substances.
  • To establish a combined approach using live-cell imaging and soft-agar assays in patient-derived xenografts (PDX) to study entity-dependent mechanisms.

Main Methods:

  • Live-cell imaging to monitor cell proliferation and cell cycle progression.
  • Soft-agar colony assays to assess tumor growth and survival.
  • Utilizing cultured patient-derived xenografts (PDX) to model in vivo tumor biology.

Main Results:

  • The study established a combined approach to analyze antimitotic drug effects on cell proliferation and apoptosis.
  • Investigated the influence of conventional and targeted antimitotic substances on mitosis and apoptosis.
  • Aimed to identify entity-dependent mechanisms of drug action and combinations in PDX models.

Conclusions:

  • Combination therapies involving antimitotic agents with proteasome inhibitors or APC/C inhibitors show promise for cancer treatment.
  • Enhancing mitotic arrest and apoptosis through targeted inhibition strategies may improve therapeutic responses.
  • The established PDX model provides a platform for studying drug efficacy and mechanisms in a more clinically relevant context.
Keywords:
Anaphase-promoting complex/cyclosome (APC/C)Antimitotic therapyCyclin BLive-cell imagingMitotic exitMitotic slippagePatient-derived xenograft (PDX)Soft-agar colony assay

More Related Videos

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.9K
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K